(Save Upto 40%)
Pertuzumab is an antineoplastic agent used in the treatment of HER2-positive metastatic breast cancer in combination with other antineoplastic agents.
Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (subdomain II) of the human epidermal growth factor receptor 2 protein (HER2)
It was first approved by the FDA in 2012 for use with docetaxel and another HER2-targeted monoclonal antibody, trastuzumab, in the treatment of metastatic HER2-positive breast cancer.
This medicine may reduce the number of blood cells (decrease white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with the heart, liver, and kidney.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using.
Perjeta helps most people with HER2 positive breast cancer, but it may have some unwanted side effects in some people.
Because Perjeta may be used with other medicines that treat breast cancer, it may be difficult for your doctor to tell whether the side effects are due to Perjeta or due to the other medicines.
Ans : Perjeta 420mg can damage the heart muscle and increase the risk of heart problems. Notify your doctor if you have any history of heart problems.
Ans : Yes, using contraception during and after treatment with Perjeta 420mg injection for at least six months is necessary.
Ans :No, Perjeta should not be self-administered and must be given only under the supervision of a healthcare professional.
Ans :Inform your doctor about the history of your high blood pressure, irregular heartbeat, heart failure, and other heart-related problems.
Ans : Inform your doctor about the list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use because certain medications may interact with Perjeta 420mg and reduce effectiveness by causing undesirable side effects.